Skip to content

Clinical trials

Hepatitis, Chronic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20101
20141
20161
20191
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Pharmasset2
AusperBio Therapeutics Inc.1
Beijing Ditan Hospital1
Huang Haijun1
Huashan Hospital1
Novartis Pharmaceuticals1
Ruijin Hospital1
Third Affiliated Hospital, Sun Yat-Sen University1
Xiamen Amoytop Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic12
Hepatitis B6
Hepatitis B, Chronic5
Hepatitis4
Hepatitis, Viral, Human3
Liver Diseases3
Virus Diseases3
DNA Virus Infections2
Digestive System Diseases2
Liver Cirrhosis2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.